Research Article| May 01 2015 Emergency Department Visits for Children With Cancer AAP Grand Rounds (2015) 33 (5): 56. https://doi.org/10.1542/gr.33-5-56 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Emergency Department Visits for Children With Cancer. AAP Grand Rounds May 2015; 33 (5): 56. https://doi.org/10.1542/gr.33-5-56 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search toolbar search search input Search input auto suggest filter your search All PublicationsAll JournalsAAP Grand RoundsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP NewsAll AAP Sites Search Advanced Search Topics: cancer, childhood cancer, emergency service, hospital, hospital admission Source: Mueller EL, Sabbatini A, Gebremariam A, et al. Why pediatric patients with cancer visit the emergency department: United States, 2006–2010. Pediatr Blood Cancer. 2015; 62(2): 490– 549; doi: https://doi.org/10.1002/pbc.25288Google Scholar Investigators from the University of Michigan and the Hospital for Sick Children, Toronto, conducted a retrospective cohort study to determine the reasons for which children with cancer seek emergent care and the factors associated with consequent hospital admission. Using data from the Healthcare Cost and Utilization Project’s Nationwide Emergency Department Sample (NEDS), children diagnosed with cancer were selected by assessing all US pediatric emergency department (ED) encounters from 2006–2010. De-identified data included primary cancer and ED discharge, patient demographics, hospital characteristics, and inpatient data, when appropriate. Since NEDS is a national database containing a 20% stratified probability sample of all hospital-based EDs, weighted analyses were conducted to attain representative estimates of ED visits, disposition status, and factors relating to admission. Characteristics of visits that led to discharge from the ED versus hospital admission were compared using regression analysis. A total of 294,289 ED visits for children with cancer, aged 0–19 years, representing 0.2% of all nationwide pediatric ED evaluations over this 5-year period, were analyzed. Acute lymphoblastic leukemia comprised 25.9% of malignancies in this cohort, followed by central nervous system tumor (8.1%) and acute myelogenous leukemia (7.5%). Of the top 10 reasons for ED encounters, fever and febrile neutropenia (FN) represented 19.2% of the visits, blood stream infections 4.3% of visits, upper respiratory infection 2.8%, pneumonia 2.5%, and neutropenia 2.2%. Overall, 43.6% of ED visits led to admission for the child at the same hospital as the ED, with highest admission rates for FN (82.3%), neutropenia (80.1%), blood stream infection (74.7%), and pneumonia (67.8%). The average transfer rate to another hospital was 3.7% with highest transfer rates for seizures (9.9%), FN (6.5%), and neutropenia (6.2%). Approximately 0.1% of children with cancer died in the ED. Variables significantly associated with admission versus discharge included age <4 years compared to age 15–19 years, having the highest quartile of median household income compared to the lowest, and having public insurance compared to self-pay status. Children presenting to metropolitan teaching hospitals were more likely to be admitted, while children presenting to non-metropolitan hospitals were less likely to be admitted compared to those attending a metropolitan non-teaching hospital. Children presenting with FN, neutropenia only, pneumonia, and dehydration were more likely to be admitted than discharged home. The authors conclude that children with cancer present to EDs most commonly with fever and FN. Younger age, having FN or neutropenia, and socioeconomic issues were associated with hospital admission from the ED. Dr Hogan has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. Despite improved outcomes for children diagnosed with cancer, immunosuppression remains a common and potentially lethal toxicity related to current chemotherapy, radiotherapy, and immunotherapy. In addition, surgically implanted... You do not currently have access to this content.
Read full abstract